Categories: News

Nuance to Release First Quarter Fiscal 2021 Results on Feb. 8, 2021

BURLINGTON, Mass., Jan. 15, 2021 /PRNewswire/ — Nuance Communications, Inc. (NASDAQ: NUAN) today announced that it will release its first quarter fiscal 2021 results on Monday, February 8, 2021 after the market close.

In addition to a press release, Nuance will provide a copy of prepared remarks. The prepared remarks are offered as additional detail and will not be read on the call. The materials will be available at https://investors.nuance.com/

The conference call will begin at 5:00 p.m. ET. The call can be accessed via webcast here, or by dialing 1-888-317-6003 (US and Canada) or 1-412-317-6061 (international) and referencing code 9035615.

About Nuance Communications, Inc.
Nuance Communications (NASDAQ: NUAN) is a technology pioneer with market leadership in conversational AI and ambient intelligence. A full-service partner trusted by 90 percent of U.S. hospitals and 85 percent of the Fortune 100 companies worldwide, Nuance creates intuitive solutions that amplify people’s ability to help others.

Trademark reference: Nuance and the Nuance logo are registered trademarks or trademarks of Nuance Communications, Inc. or its affiliates in the United States and/or other countries. All other trademarks referenced herein are the property of their respective owners.

Contact Information

For Investors
Michael Maguire
Senior Director of Investor Relations
Nuance Communications, Inc.
+1 781.565.4855
michael.maguire@nuance.com 

View original content to download multimedia:http://www.prnewswire.com/news-releases/nuance-to-release-first-quarter-fiscal-2021-results-on-feb-8-2021-301208854.html

SOURCE Nuance Communications

Staff

Recent Posts

Universal Brain Announces Publication of Groundbreaking Depression Research Using Multiple Event-Related Potentials

New findings support the company's neuroscience-driven approach to precision psychiatry, offering actionable insights for personalized…

2 hours ago

Iktos and Cube Biotech Announce Launch of Small Molecule AI Drug Discovery Collaboration

Partnership will leverage Iktos's AI-enabled drug discovery platform and Cube Biotech's advanced protein technologies to…

2 hours ago

MimiVax and UI Pharmaceuticals Achieve Milestone in SurVaxM Production for Glioblastoma Treatment

SurVaxM is the first drug product to be produced in UI Pharmaceuticals new facilityUI Pharmaceuticals…

2 hours ago

RingConn Takes Center Stage at CES 2025 with Innovative Wearables: Gen 2 and Gen 2 Air

LAS VEGAS, Jan. 10, 2025 /PRNewswire/ -- RingConn, a leading smart wearable brand, is proud…

2 hours ago

1933 Industries Provides Update on Status of Filing Delay for 4th Quarterly Report and Announces Management Changes

VANCOUVER, BC / ACCESSWIRE / January 10, 2025 / 1933 Industries Inc. (the "Company" or…

2 hours ago